Clinical Trial Update: MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing MV-NIS versus investigator's choice chemotherapy in patients with ovarian, fallopian tube, or primary peritoneal cancer; the study was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Investigator's Choice Chemotherapy
• MV-NIS

Snippet

Sponsor: Mayo Clinic | Conditions: Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-11-17